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Abstract 
Background and purpose 
Radiotherapy that selectively avoids irradiating highly-functional lung regions may reduce 
pulmonary toxicity. We report on the first clinical implementation and patient treatment of lung 
functional image-guided radiotherapy using an emerging technology, computed tomography 
(CT) ventilation imaging. 
 
Material and methods 
A protocol was developed to investigate the safety and feasibility of CT ventilation functional 
image-guided radiotherapy. CT ventilation imaging is based on (1) deformable image 
registration of four-dimensional (4D) CT images, and (2) quantitative image analysis for regional 
volume change, a surrogate for ventilation. CT ventilation functional image-guided radiotherapy 
plans were designed to minimize specific lung dose–function metrics, including functional V20 
(fV20), while maintaining target coverage and meeting standard constraints to other critical 
organs. 
 
Results 
CT ventilation functional image-guided treatment planning reduced the lung fV20 by 5% 
compared to an anatomic image-guided plan for an enrolled patient with stage IIIB non-small 
cell lung cancer. Although the doses to several other critical organs increased, the necessary 
constraints were all met. 
 
Conclusions 
An emerging technology, CT ventilation imaging has been translated into the clinic and used in 
functional image-guided radiotherapy for the first time. This milestone represents an important 
first step toward hypothetically reduced pulmonary toxicity in lung cancer radiotherapy. 
 
 
  
Introduction 
Pulmonary toxicity is substantial in lung cancer radiotherapy, particularly for locally advanced 
disease [1], [2]. Symptomatic (grade ⩾2) radiation pneumonitis is a common toxicity that occurs 
in approximately 30% of patients irradiated for lung cancer, with fatal pneumonitis in about 2% 
[1], [2]. The current paradigm of radiotherapy is based on anatomic imaging and assumes a 
homogeneous radiation dose–response of normal tissues. Radiotherapy that selectively avoids 
irradiating highly-functional lung regions may reduce pulmonary toxicity. This hypothesis is 
supported by several reports in the literature, demonstrating that lung dose–function metrics 
improve predictive power for pulmonary toxicity compared to dose–volume metrics (the current 
clinical standard) [3], [4]. For example, the functional V20 (fV20) (percent lung function receiving 
⩾20 Gy) was demonstrated to correlate more strongly with grade ⩾3 pneumonitis than the V20 
(percent lung volume receiving ⩾20 Gy) [4]. Furthermore, information of regional lung function 
(e.g., defect) was found to be useful in predicting toxicity [5], [6], [7]. 
 
Several modalities exist for lung ventilation imaging [8], [9], [10], including an emerging 
method based on four-dimensional (4D) computed tomography (CT) and image 
processing/analysis [11], [12], henceforth referred to as CT ventilation imaging. CT ventilation 
imaging has a higher resolution, lower cost, shorter scan time, and/or greater availability, 
compared to other modalities, e.g., nuclear medicine and magnetic resonance (MR) imaging. 
Moreover, CT ventilation can be considered ‘free’ information in lung cancer radiotherapy, as 
4D CT is currently in routine use at many centers and ventilation computation only involves 
image processing/analysis. Thus, CT ventilation imaging has a higher potential for widespread 
clinical implementation and would facilitate multi-institutional clinical trials as discussed in an 
editorial of a recent issue of Radiotherapy and Oncology [7]. The accuracy and reproducibility of 
CT ventilation imaging have been investigated extensively through animal studies [13], [14] and 
human studies [14], [15], [16], [17], [18]. Reasonable correlations with pulmonary function tests 
(PFTs) [17], [18] and other ventilation imaging modalities [13], [15], [17] indicate physiologic 
significance of CT ventilation imaging. See Appendix A for a full summary of the previous 
studies comparing CT ventilation with other modalities, most of which have demonstrated 
moderate to strong correlations. 
 
Dosimetric significance of lung functional image-guided radiotherapy planning has been 
demonstrated by several investigators [19], [20], [21], [22], [23]. However, it is not known 
whether such dosimetric significance leads to clinical significance. Ultimately clinical trials are 
needed to test this hypothesis. In this paper, we describe the first clinical implementation and 
patient treatment of CT ventilation functional image-guided radiotherapy for lung cancer through 
a prospective clinical trial. 
 Materials and methods 
Clinical trial protocol and patients 
A protocol (NCT02308709) (details available upon request from the corresponding author) was 
developed for a prospective clinical trial to investigate the safety and feasibility of CT ventilation 
functional image-guided radiotherapy. The primary endpoint is any grade ⩾3 adverse events 
defined as definitely, probably, or possibly related to the protocol treatment over the first 12 
months of follow-up or drop-out due to intolerance of treatment. The necessary institutional 
review board and legal processes were completed prior to patient enrollment. The legal processes 
included an agreement between the Regents of the University of California (UC) and Philips 
Healthcare, providing software and hardware. We report implementation of CT ventilation 
functional image-guided radiotherapy in the first patients enrolled on this clinical trial, and 
provide dosimetric results of one enrolled patient with stage IIIB non-small cell lung cancer 
(NSCLC). 
 
CT ventilation imaging 
CT ventilation imaging is based on (1) deformable image registration (DIR) of 4D CT images, 
and (2) quantitative image analysis for regional volume change, a surrogate for ventilation. 4D 
CT scans were acquired using a Brilliance Big Bore multislice CT scanner (Philips Healthcare, 
Andover, MA). The respiratory signal was acquired using a pneumatic belt. The following 
standard 4D CT scan parameters were used: 120 kVp, 120 mA, and 2 mm slice thickness. DIR 
was performed for spatial mapping of the peak-inhalation 4D CT image (moving image) to the 
peak-exhalation image (fixed image). We employed a volumetric elastic DIR method that 
minimizes both a similarity function (sum of squared difference) and a regularization term 
(elastic regularization) [24]. The DIR method has been previously evaluated thoroughly [24], 
[25], [26] and demonstrated to achieve sub-voxel target registration errors on average [24]. 
Regional volume change was quantified using the Hounsfield unit (HU)-based metric. See 
Appendix B for further details on the HU-based metric. 
 
CT ventilation functional image-guided radiotherapy 
CT ventilation functional image-guided radiotherapy plans are designed to selectively avoid 
irradiating highly-functional lung regions and meet specific dose–function constraints, while 
maintaining target coverage and meeting standard constraints to other critical organs (Table 1). 
The lung dose–function constraints were determined based on Vinogradskiy et al. [4], and are 
estimated to yield a lower rate of radiation pneumonitis. Treatment is given 5 days per week for 
30 days in 2 Gy fractions daily (60 Gy in total) using 6 MV photon beams for patients receiving 
conventionally-fractionated radiotherapy with or without chemotherapy (concurrent 
chemotherapy for the patient reported in this paper). The same prescription dose and constraints 
to critical organs are used regardless of whether chemotherapy is used. Both intensity-modulated 
radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) are allowed. 
The dose of 60 Gy was prescribed to 95% of the planning target volume (PTV). The minimum 
dose and maximum dose to the PTV must be ⩾90% and ⩽115% of the prescription dose, 
respectively. The gross tumor volume (GTV) was defined as the primary tumor and any 
regionally involved lymph nodes identified by treatment planning CT images (>1 cm on short 
axis). The internal target volume (ITV) was defined as the envelope that encompassed the GTV 
plus a full range of motion of the primary tumor and nodal target identified by 4D CT. A 
maximum intensity projection (MIP) image and peak-exhalation/inhalation 4D CT images were 
also used. The clinical target volume (CTV) was determined by adding a margin of 5–10 mm to 
the ITV at the discretion of the treating physician. The PTV was determined by adding an 
additional margin of 5 mm to the CTV. 
 
Major critical organs were contoured as follows. The spinal cord was contoured as the bony 
limits of the spinal canal at least 10 cm cranial and caudal to the PTV. The heart along with the 
pericardial sac was contoured from its base to apex. The entire circumference of the esophagus 
including the outermost fatty adventitia was contoured at least 10 cm cranial and caudal to the 
PTV. 
 
IMRT and VMAT optimization for CT ventilation functional image-guided radiotherapy is based 
on a non-uniform weight (importance) factor map of the lung generated from a ventilation 
image, which is incorporated into a cost function. The Pinnacle3 treatment planning system, 
research version 9.7 (Philips Radiation Oncology Systems, Fitchburg, WI) was used in the 
current implementation. The lung weight factor map was generated by converting CT ventilation 
images into percentile distribution images in a manner similar to Vinogradskiy et al. [4]. The 
following two types of lung dose–function objectives were developed: (1) maximum fVx 
(percentage of ventilation receiving ⩾x Gy), and (2) maximum functional mean lung dose 
(fMLD) (MLD weighted by regional ventilation). See Appendix C for further details on the lung 
weight factor map and IMRT/VMAT cost function. For IMRT, the beam angles are optimized 
manually to avoid passing through highly-functional lung regions. 
 
Clinical process 
The clinical processes included (1) CT ventilation computation, (2) CT ventilation functional 
image-guided treatment planning, (3) patient-specific quality assurance (QA), and (4) treatment 
delivery. First, CT ventilation computation was performed using a standalone research computer 
on which the software for DIR and ventilation computation is installed. Given that ventilation 
computation only involves image processing/analysis, this process could potentially be 
seamlessly integrated into a treatment planning system in a commercial application. Second, a 
functional image-guided treatment plan was created by an experienced dosimetrist, who was 
trained beforehand, using the resulting CT ventilation weight factor map on Pinnacle3, research 
version 9.7. IMRT with ten non-coplanar beams was used for the patient reported in this paper. 
Intensity modulation was performed using the direct machine parameter optimization (DMPO) 
algorithm, where the maximum number of multileaf collimator (MLC) segments was set at ten. 
For a comparison purpose, an anatomic image-guided plan was also created without using any 
prior knowledge of regional ventilation of the patient. The resulting functional image-guided 
plan was transferred to Pinnacle3, clinical version 9.10 for the final dose calculation and review. 
Third, patient-specific QA was performed through independent monitor unit (MU) calculation 
and measurement of absolute dose distributions. The results were evaluated based on the same 
criteria used for standard treatments at UC Davis. Lastly, treatment was delivered with daily kV 
cone-beam CT (CBCT) guidance. 
 
Results 
Fig. 1 shows a comparison between the CT ventilation functional image-guided IMRT plan and 
comparison anatomic image-guided plan of an enrolled patient with stage IIIB NSCLC. The dose 
to highly-functional lung regions including the right posterior and left anterior/medial regions 
was reduced with CT ventilation functional image guidance. The lung fV20 was reduced by 5% 
from 29.7% to 24.6%. The fMLD was almost identical, i.e., 18.3 Gy in the anatomic image-
guided plan vs. 18.1 Gy in the functional image-guided plan. For the dose–volume metrics, the 
V20 was reduced by 4.4% from 32.8% to 28.3%, whereas the V5 increased considerably by 
10.6% from 79.7% to 90.3%. The MLD was almost identical, i.e., 18.9 Gy vs. 19.1 Gy, 
suggesting that the reduction in dose–function metrics were not attributed to overall reduction of 
the lung dose but rather selective avoidance of highly-functional regions. The anatomic image-
guided plan created without using any prior knowledge of regional ventilation resulted in the 
lung V20 of 32.8% that was well below the limit (37%), and hence the plan was not further 
optimized to reduce the V20. Using CT ventilation images, the fV20 of anatomic image-guided 
plan was calculated to be 29.7% that was just below the limit (30%). CT ventilation functional 
image-guided planning was performed to reduce the fV20. For other structures, the PTV dose 
homogeneity was degraded with a higher maximum dose, i.e., 67.4 Gy (anatomic) vs. 69.0 Gy 
(functional). Also the maximum spinal cord dose and mean esophageal dose increased (cord, 
44.4 Gy vs. 46.5 Gy; esophagus, 38.6 Gy vs. 40.0 Gy). However, the functional image-guided 
plan met all the target dose specifications and constraints to the critical organs, except for the 
optional mean esophageal dose constraint of 34 Gy. The measurement of absolute dose 
distributions as part of the patient-specific QA process resulted in the γ passing rate (3%/3 mm) 
of 95%. 
Discussion 
This paper reports on the first patient treatment of CT ventilation functional image-guided 
radiotherapy for lung cancer. This represents the second clinical implementation of lung 
functional imaging in radiotherapy. Hyperpolarized 3He MR ventilation imaging was the first 
modality implemented in radiotherapy in 2014 [27]. There are three major differences between 
these two implementations. First, CT ventilation imaging has a higher potential for widespread 
clinical implementation than hyperpolarized gas MR ventilation imaging. CT ventilation can be 
considered ‘free’ information in lung cancer radiotherapy, as 4D CT scans are currently in 
routine use at many radiotherapy centers and ventilation computation only involves image 
processing and analysis. Currently 4D CT is estimated to be used at approximately 70% of 
centers in the US, extrapolated from survey results by Simpson et al. [28]. CT ventilation 
imaging would also facilitate multi-institutional clinical trials as recently discussed by Ebert et 
al. [7]. By contrast, hyperpolarized 3He MR ventilation imaging is limited by high costs, low 
availability, and poor global supply of 3He gas. Second, CT ventilation images can be more 
easily registered to the planning CT image than MR ventilation images. Unlike MRI, 4D CT 
scans are usually acquired during the same session in the same position as the planning CT 
scans. The differences in the scan acquisition time, position, and breathing maneuver between 
MRI and planning CT make image registration difficult. Lastly, the voxel-based functional 
avoidance strategy was employed in the current implementation, whereas the sub-volume-based 
strategy was used in the hyperpolarized 3He MR study. For dose painting, the voxel-based 
strategy (dose painting by numbers) was demonstrated to have dosimetric advantages over the 
sub-volume-based strategy (sub-volume boosting) [29]. 
 
The impact of lung functional image-guided treatment planning would vary with regional 
function, target size, location and delivery technique [20], [23]. Reductions in lung dose–
function metrics may be greater for future patients to be enrolled in this trial than the patient 
described above. Lung functional avoidance is sometimes achieved at the expense of increased 
doses to other critical organs and/or degraded target dose homogeneity and conformity [21], [23] 
as observed for the patient reported in this paper. This raises a concern that lung functional 
image-guided radiotherapy might increase risk of non-pulmonary toxicity for some patients. 
Moreover, the lung volume receiving low doses for the patient reported in this paper was 
considerably larger in the functional image-guided plan (90.3%) than in the anatomic image-
guided plan (79.7%). This raises a concern of pulmonary toxicity [30] as well, especially given 
that the V5 < 65% is recommended by several investigators [2] and used as a constraint in several 
trials including RTOG 1106. Our trial does not include V5 as a constraint, but rather V20 and 
MLD in a manner similar to RTOG 0617. We will track various dose–volume metrics including 
those that are not used as a constraint, and assess any acute and late adverse events. 
 
This ongoing clinical trial will enroll a total of 20 patients and analyze the rate of any grade ⩾3 
adverse events over the first 12 months of follow-up or drop-out due to intolerance of treatment. 
The success of this study, i.e., a rate of grade ⩾3 adverse events less than 30% (derived from the 
published toxicity data) will provide a necessary justification for proceeding with a larger 
clinical trial (e.g., multi-institutional trial) to examine whether CT ventilation functional image-
guided radiotherapy reduces pulmonary toxicity. 
 
Clinical translational relevance 
An emerging imaging technology, CT ventilation imaging has been translated into the clinic and 
used in functional image-guided radiotherapy for the first time. This milestone represents an 
important first step toward hypothetically reduced pulmonary toxicity in lung cancer 
radiotherapy and widespread implementation of CT ventilation imaging. Upon successful 
completion of this trial, we will conduct a larger clinical trial to examine the efficacy of CT 
ventilation functional image-guided radiotherapy. 
 
  
Table 1. Dose–volume/function constraints to critical organs. 
Critical organ Constraint 
Lung V20 < 37% 
MLD < 20 Gy 
Functional V20 (fV20) <30% 
Functional MLD (fMLD) <19 Gy 
Spinal cord Max dose < 47 Gy 
Esophagus Max dose < 70 Gy 
Mean dose <34 Gya 
Heart Max dose < 70 Gy 
V60 < 33% 
V45 < 66% 
Abbreviations: Vx = percent volume receiving ⩾x Gy, MLD = mean lung dose. 
a Only a guideline and will not be scored as a protocol deviation if not achieved. 
 
 
  
  
Fig. 1. Comparison of the CT ventilation functional image-guided IMRT plan and comparison anatomic image-
guided plan: (a) isodose curves, (b) dose–volume histograms (DVHs) of the PTV (red) and critical organs 
(esophagus, brown; heart, purple; spinal cord, green; and lung, blue), and (c) lung dose–function histograms 
(DFHs) for an enrolled patient with stage IIIB NSCLC. The dose to highly-functional lung regions was reduced 
with functional image guidance (red arrows). A ventilation weight factor map is overlaid on the CT image. In 
the DVHs and DFHs, the solid and dashed lines denote the ventilation functional image-guided plan and 
anatomic image-guided plan, respectively. 
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Appendix A: Summary of the previous studies comparing CT ventilation imaging with other modalities 
 
Study Modality Subjects Key finding 
Yamamoto et al. [1] PFT 15 human subjects Moderate correlations (range 0.43-0.73) between CT ventilation-defined 
defect parameters and PFT parameters 
Brennan et al. [2] PFT 98 human subjects Moderate correlations (range 0.63-0.72) between CT ventilation-defined 
parameters (heterogeneity and defect) and PFT parameters 
Fuld et al. [3] Xenon-CT 4 sheep Strong correlation (0.81) of regional ventilation  
Reinhardt et al. [4] Xenon-CT 5 sheep Strong correlation (0.85) of regional ventilation 
Mathew et al. [5] Hyperpolarized 3He MRI 11 human subjects Strong DSCs (0.86-0.88) of ventilated volumes 
Vinogradskiy et al. [6] 99mTc-DTPA scintigraphy 15 human subjects Moderate correlation (0.68) of % ventilation of each lung 
Castillo et al. [7] 99mTc-DTPA SPECT 7 human subjects Weak DSC (0.35) of poorly-ventilated volumes likely due to central airway 
deposition of aerosols 
Yamamoto et al. [1] 99mTc-DTPA SPECT 16 human subjects Significantly lower CT ventilation in SPECT-defined defect regions than in 
non-defect regions 
Kipritidis et al. [8] 68Ga-aerosol (Galligas) PET 12 human subjects Strong DSC (0.88) of ventilated volumes; moderate DSC (0.52) of poorly-
ventilated volumes; moderate (0.42) correlation of regional ventilation 
Abbreviations: PFT = pulmonary function test, 99mTc-DTPA = technetium-99m-labeled diethylenetriamine pentaacetate, DSC = Dice similarity coefficient. 
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Appendix B: Derivation of the Hounsfield unit-based ventilation metric 
 
Simon [1] derived a relationship between the regional change in fractional air content and regional volume 
change, which was adapted to the relationship between the local Hounsfield unit (HU) change and local 
volume change by Guerrero et al. [2].  The specific ventilation in the voxel at location  is given by 
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where HU  is the HU value and u  is the displacement vector mapping the voxel at location  of a peak-
exhalation 4D-CT image to the corresponding location of a peak-inhalation image.  inHU  represents the peak-
inhalation HU value after correction for the lung mass variation from the peak-exhalation phase (see below).  
Note that the air and tissue densities were assumed to be -1000 and 0 HU, respectively.  The peak-exhalation 
air volume ( airexVol ) in the voxel at location  can be estimated by 
 
     zyxzyxzyx ,,Vol
1000
,,HU,,Vol voxelexex
air
ex  , (2) 
 
where voxelexVol  is the peak-exhalation voxel volume [3].  Substitution of Equation (2) into Equation (1) yields 
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Given that voxelexVol  is identical for all voxels, the HU-based ventilation metric ( ) was defined as: 
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where scaling  is the CT density scaling factor , which takes a value ranging from 0 
for the voxel with the lowest lung CT density (-1024 HU) to 1 for the voxel with the highest density (-250 HU) 
[4, 5].  The rationale for density scaling is to transform a purely mechanical model of regional ventilation based 
on volume change alone to a more physiological model.  Gas transport to high alveolar density regions 
contributes more to gas exchange, and hence is considered more physiologically relevant compared to gas 
transport to low alveolar density regions.  It was assumed that alveolar density was proportional to CT density.   
 
The peak-inhalation HU values were corrected for the lung mass variation from the peak-exhalation phase in 
the same manner as Guerrero et al. [6] by 
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where f  denotes the fractional difference in the lung mass between the peak-exhalation and peak-inhalation 
phases.  Lung perfusion increases with inhalation due to several factors including distension of blood vessels 
and variation in cardiac output, leading to increased lung mass [6, 7]. 
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Appendix C: Cost function for CT ventilation functional image-guided IMRT/VMAT optimization 
 
Optimization is based on minimization of a cost function that is proportional to the sum of the objectives times 
the weight factors.  A cost function Φ for CT ventilation functional image-guided IMRT/VMAT optimization is 
expressed as 
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where ܰ is the number of voxels in the lung, ܯ is the number of lung dose-function objectives, ߶ is a function 
of the lung dose-function objective ܿ, dose ܦ௞ deposited in the voxel ݇, and regional weight factor ݓ௞ of the 
voxel ݇, and ߟ௖  is the global weight factor assigned to the objective ܿ.  The regional weight factor ݓ௞  was 
determined as follows.  CT ventilation images were converted into percentile distribution images by replacing 
the ventilation value of each voxel with the corresponding cumulative distribution function (ܥܦܨ௞) scaled to the 
range [0, 1] in a manner similar to Vinogradskiy et al. [1].  When the ventilation value of the voxel ݇ is denoted 
by ௞ܸ, the regional weight factor, ݓ௞	 is given by  
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where ௞ܰ is the number of voxels with a ventilation value in the range of ሾ0, ௞ܸሿ.  The following two types of 
lung dose-function objectives were developed: (1) maximum fVx (percentage of total ܥܦܨ௞ receiving ≥x Gy), 
and (2) maximum functional mean lung dose (fMLD) (MLD weighted by ܥܦܨ௞).   
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